UPDATE: Exact Sciences' Q1 Revenues Drop 23 Percent | GenomeWeb

The story has been updated to include comments from company officials from its conference call.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Exact Sciences today reported a 23 percent drop in revenues year over year while its net loss more than doubled during the first quarter.

The Madison, Wis.-based molecular diagnostics firm said that for the three months ended March 31, revenues came in at $1 million, down from $1.3 million a year ago and short of analyst expectations of $1.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.

Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.

MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.

Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.